Los Angeles, Inc.

MONTEBELLO, Calif., Sept. 26, 2024 /PRNewswire/ -- Adventist Health White Memorial Montebello celebrated its 100th surgery utilizing the da Vinci Xi Surgical System, a medical milestone that has helped patients in the community achieve better outcomes with minimally invasive surgery procedures. Continue Reading Nani Gelvezon (center, black scrubs), DO, General Surgeon, Adventist Health White Memorial Montebello, with the Surgery team. Dr. Gelvezon completed the hospital’s 100th robotic surgery procedure. "Adventist Health White Memorial is pleased to bring the advanced technology of the da Vinci Xi system to the patients and surgeons of Montebello. Also known as "robotic surgery" the minimally invasive procedures performed with the Da Vinci system allow more patients to get the best surgery to meet their needs without leaving their community," said Mark Dumais, MD, Medical Officer, Adventist Health White Memorial Montebello. Surgeons at Adventist Health White Memorial Montebello began offering robotic surgery for our community in April of this year. Already 100 patients have benefited from this technology. The da Vinci Xi surgical system can be used across a spectrum of minimally invasive surgical procedures and may result in smaller incisions, less blood loss, and shorter hospital stays when compared to traditional open surgical procedures. The surgeons at Adventist Health White Memorial Montebello are leaders in this field and look forward to continually bringing advanced minimally invasive surgical options to their community. About Adventist Health White Memorial: Keeping communities healthy has been our mission ever since our Los Angeles hospital was founded in 1913. Today, Adventist Health White Memorial boasts two sites: Los Angeles is an inner-city safety net medical center with a 353-bed acute care hospital, providing a full range of inpatient, outpatient, emergency, and diagnostic services. Embracing our legacy as a teaching hospital, we continue to pioneer physician and nurse residency programs, shaping the future of healthcare professionals. We recently acquired our Montebello facility, established in 1949, to expand our reach. Comprising a 192-bed hospital equipped with emergency services, a wound care clinic, and medical offices, we extend our commitment to quality medical care and community service. As part of Adventist Health, a faith-based, nonprofit health system, we serve over 100 communities across the West Coast and Hawaii through more than 440 sites of care, including 28 acute care facilities. SOURCE Adventist Health White Memorial WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Eight years after first launching with $250 million to support immunological approaches to fighting cancer, the Parker Institute for Cancer Immunotherapy (PICI) announced a fresh $125 million commitment on Thursday. According to PICI, while immunotherapies are often used as a “last resort” for cancer patients, its goal is to “transform the course of cancer treatment” and improve the drug class so it can be offered as a front-line option.Over the next five years, PICI plans to draw from the new funds and issue grants to scientists in its network of research, with the aim of accelerating development of novel cancer immunotherapies. The investment will also help broaden the scope of the institute’s internal research.PICI was founded to support cross-institutional collaboration and initially linked together six universities and research centres: Stanford University, University of California, Los Angeles, University of California, San Francisco, the University of Pennsylvania, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. The network has since expanded to include Gladstone Institutes, Dana-Farber Cancer Institute, Weill Cornell Medicine, City of Hope, and Fred Hutchinson Cancer Center.To date, PICI has supported 440 research projects and clinical trials, which were led by more than 850 scientists and support staff within the institute’s network.Outside of that network, PICI has helped fund 17 biotechs developing immunotherapies for cancer. The organisation expects to put any returns generated from these investments towards additional research grants, “creating a sustainable cycle of innovation and discovery.”

LOS ANGELES--( BUSINESS WIRE )--City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, has been recognized as having one of the nation’s top 5 hospitals for cancer care, according to U.S. News & World Report’s 2024-25 rankings. City of Hope is the only California-based cancer institution ranked in the top 5. The recognition marks the latest milestone for City of Hope as it enhances its ability to make a meaningful impact in the lives of patients, families and communities nationwide. “City of Hope has been on an extraordinary journey to make new research breakthroughs and lifesaving treatments readily accessible to everyone touched by cancer,” said Robert Stone, CEO of City of Hope and the Helen and Morgan Chu Chief Executive Officer Distinguished Chair. “This ranking reflects our dedicated team’s ability to deliver on our most important goal — saving lives.” The placement on the “Best Hospitals” for cancer list was due to several factors, including high marks for patient outcomes and survival data, advanced clinical capabilities, technology and reputation among oncology specialists. City of Hope is home to many of the world’s top experts across a range of complex cancer types and innovative technologies, with more than 550 physicians and 1,000 researchers and scientists part of its nationally integrated system. The system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix metropolitan areas. In addition to City of Hope’s National Medical Center in Los Angeles being ranked as one of the nation’s top 5 hospitals for cancer care, the center was rated as “high performing” for all six cancer procedures and conditions measured by U.S. News & World Report: lung cancer surgery, colon cancer surgery, prostate cancer surgery, gynecologic cancer surgery, gastroenterology and GI cancer surgery, as well as in the treatment of leukemia, lymphoma and myeloma. City of Hope Atlanta was rated as “high performing” in colon cancer surgery, and City of Hope Chicago was rated as “high performing” in gynecologic cancer surgery. With a National Cancer Institute-designated academic cancer center at its core, City of Hope is a global leader in translating breakthrough research into effective treatments through collaboration and scientific exploration. This includes: The country’s largest, and one of the most successful and internationally recognized, bone marrow transplantation programs (BMT). City of Hope remains a pioneer in BMT and cellular therapies, with locations across the country offering breakthrough treatments for all hematologic malignancies. More than 850 clinical trials each year, with an expansive geographical footprint that provides access to innovative therapies for patients across the U.S. An “Exceptional” rating, the highest possible, from the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training. This places the center in the top echelon of the nation’s 57 NCI-designated comprehensive cancer centers. More than 86 million people now live in communities with local access to a City of Hope location. Last year, the organization treated more than 144,000 patients. To view the complete U.S. News & World Report rankings, visit: usnews.com/best-hospitals . About City of Hope City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines , as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope TM . For more information about City of Hope, follow us on Facebook , X , YouTube , Instagram and LinkedIn .